Komipharm International Co. Ltd Cash Flow-to-Debt Ratio
Komipharm International Co. Ltd cash flow-to-debt ratio. Komipharm International Co. Ltd (041960) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of ₩946.94 Million could theoretically repay 0% of its total liabilities (₩61.86 Billion) in one year. Check 041960 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Komipharm International Co. Ltd (2013–2025)
Cash flow-to-debt ratio of Komipharm International Co. Ltd from 2013 to 2025. Historical debt coverage capacity for Komipharm International Co. Ltd across 13 annual periods. Check Komipharm International Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Komipharm International Co. Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
Komipharm International Co. Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Komipharm International Co. Ltd. For the full cash flow conversion analysis, see how efficiently does Komipharm International Co. Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | ₩-621.80 Million | ₩61.86 Billion | ▼ -106.5% |
| 2024 | 0.15x | ₩8.85 Billion | ₩57.23 Billion | ▲ +423.5% |
| 2023 | -0.05x | ₩-2.80 Billion | ₩58.58 Billion | ▼ -35.1% |
| 2022 | -0.04x | ₩-1.81 Billion | ₩51.12 Billion | ▼ -37.4% |
| 2021 | -0.03x | ₩-1.26 Billion | ₩48.80 Billion | ▼ -4760.6% |
| 2020 | 0.00x | ₩25.20 Million | ₩45.64 Billion | ▼ -97.0% |
| 2019 | 0.02x | ₩950.79 Million | ₩52.37 Billion | ▲ +141.9% |
| 2018 | -0.04x | ₩-2.02 Billion | ₩46.52 Billion | ▼ -983.6% |
| 2017 | 0.00x | ₩235.64 Million | ₩48.00 Billion | ▼ -77.0% |
| 2016 | 0.02x | ₩1.21 Billion | ₩56.64 Billion | ▲ +141.7% |
| 2015 | -0.05x | ₩-2.93 Billion | ₩57.26 Billion | ▼ -43.7% |
| 2014 | -0.04x | ₩-2.54 Billion | ₩71.24 Billion | ▼ -158.0% |
| 2013 | 0.06x | ₩3.93 Billion | ₩64.08 Billion | — |